Wyeth-Ayerst Effexor, Effexor XR
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Venlafaxine approved May 2 for prevention of relapse and recurrence of depression. Effexor XR's previous depression indication was based on studies up to 12 weeks long